Company: LNAI
Filing Date: 2025-09-24
Form Type: 8-K
Source: 0001731122-25-001297
Chunk: 1

Company: Lunai Bioworks Inc.
Filing Date: 2025-09-24
Form: 8-K
Item: Item 5.03
Chunk 1
---
Item
5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

On
September 18, 2025, Lunai Bioworks, Inc. (the “ Company Certificate of Amendment Common Stock Reverse Stock Split

On
August 15, 2025, stockholders owning a majority of the outstanding voting capital stock of the Company entitled to vote thereon approved
a corporate action by Special Meeting of Stockholders authorizing the Company’s board of directors (the “ Board

As
a result of the Reverse Stock Split, every 10 shares of issued and outstanding Common Stock will be automatically combined into one issued
and outstanding share of Common Stock, without any change in the par value per share. No fractional shares will be issued as a result
of the Reverse Stock Split. Any fraction of a share of Common Stock outstanding that would be created as a result of the Reverse Stock
split will be rounded up to the next whole share. The Reverse Stock Split will reduce the number of shares of Common Stock outstanding
from 231,780,434 shares to approximately 23,178,096 shares, inclusive of adjustments for the rounding up of fractional shares. The number
of authorized shares of Common Stock under the Certificate of Incorporation will remain unchanged at 350,000,000 shares and no changes
will be made to the authorized or outstanding shares of preferred stock.

The
Common Stock will begin trading on a reverse stock split-adjusted basis on The Nasdaq Capital Market on September 30, 2025. The trading
symbol for the Common Stock is “ LNAI.” The new CUSIP number for the Common Stock following the Reverse Stock Split is 29350E
203.

A
press release announcing the split was published by the Company on September 24, 2025, a copy of which is filed herewith as Exhibit 99.1.
For more information about the Reverse Stock Split, see the Company’s notice of meeting and proxy statement on Form DEF 14A filed
with the U. S. Securities and Exchange Commission on July 30, 2025. The information set forth herein is qualified in its entirety by reference
to the complete text of the Certificate of Amendment, a copy of which is filed as Exhibit 3.1 to this Current Report and is incorporated
by reference herein.

Item
9.01 Financial Statements and Exhibits.